Cabiralizumab in Combination With Nivolumab and Neoadjuvant Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Condition: Triple Negative Breast Cancer Interventions: Drug: Paclitaxel; Drug: Carboplatin; Biological: Nivolumab; Biological: Cabiralizumab; Procedure: Tumor biopsy; Procedure: Bone marrow; Procedure: Blood draw Sponsors: Washington University School of Medicine; Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Research